Cardiologia

Um estudo de caso-controle mostrou risco aumentado de miocardite após vacinação contra COVID-19 com vacina mRNA em comparação com vacina de vírus inativado.

25 Jan, 2022 | 15:04h

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine: A Case–Control Study – Annals of Internal Medicine

Comunicado de imprensa: BNT162b2 COVID-19 vaccine associated with increased risk of carditis – American College of Physicians

Conteúdos relacionados:

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

---

Revisão JACC de estado da arte | Diagnóstico e avaliação da cardiomiopatia hipertrófica.

25 Jan, 2022 | 14:51h

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review – Journal of the American College of Cardiology

---

Revisão JACC de estado da arte | Tratamento da cardiomiopatia hipertrófica.

25 Jan, 2022 | 14:50h

Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review – Journal of the American College of Cardiology

---

Tendências globais, regionais e nacionais na mortalidade da doença cardíaca congênita, 1990–2019: análise para o estudo Global Burden of Disease 2019.

25 Jan, 2022 | 14:41h

Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study – EClinicalMedicine

 

Comentário no Twitter

A new study using data from the #GBD 2019 study estimated trends in congenital #heartdisease (CHD) mortality in 204 countries and territories over the past 30 years.

Read more here: https://t.co/6NtW0TYMAG pic.twitter.com/VLCU9OuOwx

— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) January 14, 2022

 

---

World Heart Federation afirma que nenhuma quantidade de álcool é boa para o coração.

25 Jan, 2022 | 11:51h

Comunicado de imprensa: No amount of alcohol is good for the heart, says World Heart Federation

Relatório: The Impact of Alcohol Consumption on Cardiovascular Health: Myths and Measures – World Heart Federation

Comentário: No amount of alcohol is good for the heart, new report says, but critics disagree on science – CNN

---

Diretriz AHA | Penicilina oral, e não injetável, é indicada para pessoas com doença cardíaca reumática de alto risco.

25 Jan, 2022 | 11:50h

Comunicado de imprensa: Oral penicillin, not injectable, advised for people with high-risk rheumatic heart disease – American Heart Association

Ver diretriz: Penicillin Reactions in Patients With Severe Rheumatic Heart Disease: A Presidential Advisory From the American Heart Association – Journal of the American Heart Association

---

Revisão | Intervenções para melhorar o conhecimento em saúde dos pacientes para prevenção secundária de doença arterial coronariana.

25 Jan, 2022 | 11:40h

Health literacy interventions for secondary prevention of coronary artery disease: a scoping review – openheart

---

Estudo de coorte retrospectiva | Ocorrência e preditores de efusão pericárdica que exige tratamento invasivo após cirurgia de válvula cardíaca.

25 Jan, 2022 | 11:39h

Occurrence and predictors of pericardial effusion requiring invasive treatment following heart valve surgery – openheart

---

Revisão | Tomografia computadorizada cardiovascular para avaliar o risco de doença arterial coronariana: placas, fluxo e gordura.

25 Jan, 2022 | 11:38h

Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat – Heart

---

Comentário do KDOQI US sobre a Diretriz KDIGO 2021 para o tratamento da pressão arterial na doença renal crônica.

25 Jan, 2022 | 11:29h

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD – American Journal of Kidney Diseases

Conteúdos relacionados:

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Guideline synopsis: management of blood pressure in patients with chronic kidney disease not receiving dialysis.

 

Comentário no Twitter

The @nkf KDOQI work group agreed with most of the @goKDIGO BP recommendations while highlighting the weak evidence base especially for patients with diabetes and advanced CKD ca. 2022 #Nephpearls

👉🏼 https://t.co/X40N0pacY6 https://t.co/HEHlSD06yO pic.twitter.com/Rpil8m0QOn

— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) January 21, 2022

 

---